Australia markets open in 8 hours 41 minutes

Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
15.02-0.39 (-2.53%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.06B
Enterprise value 3.64B
Trailing P/E 45.32
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.57
Price/book (mrq)2.32
Enterprise value/revenue 12.71
Enterprise value/EBITDA 35.91

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-4.48%
S&P500 52-week change 325.22%
52-week high 321.41
52-week low 313.81
50-day moving average 316.16
200-day moving average 318.04

Share statistics

Avg vol (3-month) 32.67M
Avg vol (10-day) 31.59M
Shares outstanding 5263.5M
Implied shares outstanding 6263.83M
Float 8117.24M
% held by insiders 157.02%
% held by institutions 17.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.3
Forward annual dividend yield 41.95%
Trailing annual dividend rate 30.15
Trailing annual dividend yield 30.97%
5-year average dividend yield 4N/A
Payout ratio 488.24%
Dividend date 3N/A
Ex-dividend date 430 June 2023
Last split factor 21.5:1
Last split date 330 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 32.13%
Operating margin (ttm)19.44%

Management effectiveness

Return on assets (ttm)2.04%
Return on equity (ttm)5.30%

Income statement

Revenue (ttm)286.12M
Revenue per share (ttm)1.06
Quarterly revenue growth (yoy)-18.20%
Gross profit (ttm)N/A
EBITDA 76.88M
Net income avi to common (ttm)91.94M
Diluted EPS (ttm)0.34
Quarterly earnings growth (yoy)-7.70%

Balance sheet

Total cash (mrq)790.31M
Total cash per share (mrq)3
Total debt (mrq)4.75M
Total debt/equity (mrq)0.27%
Current ratio (mrq)21.47
Book value per share (mrq)6.65

Cash flow statement

Operating cash flow (ttm)113.1M
Levered free cash flow (ttm)533.95M